top of page
Dr. Marco Gottardis describes his background in biopharma and why he’s excited to join LIfT as a Non-Executive Director
In this interview, Dr. Marco Gottardis outlines his background in cell therapy and biopharma, including his most recent role as VP of...
May 28, 2024
Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual Meeting
London, 24 May 2024 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company about to start clinical trials for...
May 24, 2024
LIfT BioSciences Awarded Innovate UK Grant to Accelerate Product Development of New IMAN Cell Therapy Variants
Groundbreaking in vivo studies will be progressed to explore the impact of IMAN cell therapies in solid tumour and immunology models...
May 16, 2024
bottom of page